Zynex Inc
NASDAQ:ZYXI
Zynex Inc
Revenue
Zynex Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Zynex Inc
NASDAQ:ZYXI
|
Revenue
$188.7m
|
CAGR 3-Years
28%
|
CAGR 5-Years
41%
|
CAGR 10-Years
27%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$21B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
Zynex Inc
Revenue Breakdown
Breakdown by Geography
Zynex Inc
Breakdown by Segments
Zynex Inc
Total Revenue:
184.3m
USD
|
Supplies:
125.5m
USD
|
Represent The Information Pertaining To Devices:
58.8m
USD
|
See Also
What is Zynex Inc's Revenue?
Revenue
188.7m
USD
Based on the financial report for Mar 31, 2024, Zynex Inc's Revenue amounts to 188.7m USD.
What is Zynex Inc's Revenue growth rate?
Revenue CAGR 10Y
27%
Over the last year, the Revenue growth was 11%. The average annual Revenue growth rates for Zynex Inc have been 28% over the past three years , 41% over the past five years , and 27% over the past ten years .